Leaving BNY Website

 

You are leaving the BNY Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2024 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
 

To learn more about DRs, please contact DRBrokerSolutions@bnymellon.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.55%), DAX (0.37%), CAC40 (0.48%)

Jan 07 ,2025

  • Synopsis

    • European equity market are set to open in negative territory amidst Asia equities tilting to the upside Tuesday: Strong gains in Japan although off its peaks now. Australia, South Korea and Taiwan with modest gains. India opened higher. Mainland China boards slightly higher but Hang Seng sharply down. Southeast Asia mixed. US futures slightly lower for now. US dollar slightly weaker to follow overnight losses, AUD and NZD continuing their overnight bounce, but yen weaker again; yuan flat. Treasury yields mixed, JGB yields at highest since July 2011, CGB yields bouncing off lows. Crude blends flat, precious metals a little higher, base metals largely unchanged. Cryptocurrencies off overnight highs

    • In central banks, ECB releases Nov Consumer Expectations Survey results at 10:00CET. Elsewhere on today's agenda, WTO Director-General Okonjo-Iweala hosts EU's Šefčovič and EU's Albuquerque participates in a debate in the Diplomatic Seminar organised by the Portuguese Foreign Affairs Office, Norway's Minister of Fisheries and Oceans Næss participates in the conf "North in South 2025" and in UK, parliamentary committee topics include review of the 2024 general election (10:00GMT), Competition and Markets Authority (CMA) (non-inquiry session) 14:30. Resolution Foundation event at 10:00GMT A squeezed middle of the decade? The political economy outlook for 2025. CES technology trade fair, Las Vegas

    • Macroeconomic updates include: Eurozone/France/Italy/Austria prelim Dec CPI, Germany/UK Dec Construction PMI, UK Dec House Price Index - Halifax, Eurozone/ Denmark/Italy Nov Unemployment Rate, Norway Nov Manufacturing Production, Switzerland Dec CPI. In addition, Kantar will release latest UK grocery market share figures.

    • In corporate news, Sodexo (SW.FP) reports Q1 sales €6.40B vs year-ago €6.29B and maintains FY guidance. In the Netherlands, InPost (IPSTA.NA) and Aperam (APAM.NA) are out with Q4 trading updates. In Germany, Mercedes-Benz Group (MBG.GR) likely to lower medium-term profit targets, Handelsblatt reported. Out of the Nordics, Lerøy Seafood Group (LSG.NO) issued Q4 trading update whilst BioPorto (BIOPOR.DC) expects 2024 adjusted EBITDA (DKK 68M) - (DKK 73M) vs FactSet (DKK 73.4M).

    • On M&A front, Julius Baer Group (BAER.SW) confirmed it is to sell its domestic Brazilian business to BTG Pactual. Helvetia (HELN.SW) is reportedly exploring sale of loss-making German insurance operations.

  • Politics/Macro/World News

    • How Nato will hold European capitals to higher defence spending promises - FT

    • UK financial regulator failed to uphold rules for handling FOI requests, review finds - FT

    • Pressure mounts on EU to use legal weapons against Musk's interference - Politico

    • German dream of becoming a global chip superpower is fading fast - Bloomberg

    • Mark Carney says he's considering running to succeed Trudeau - Bloomberg

    • Netherlands Dec Preliminary CPI +4.1% y/y vs consensus +4.2% and prior +4.0%

  • Top company news

    • Earnings/updates

      • MBG.GR (Mercedes-Benz Group) -- likely to lower medium-term profit targets - Handelsblatt

      • SW.FP (Sodexo) -- reports Q1 sales €6.40B vs year-ago €6.29B; FY guidance is maintained

      • INPST.NA (InPost) -- reports Q4 parcels 332.1M vs year-ago 268.2M

      • APAM.NA (Aperam) -- issues Q4 market update

      • SHUR.BB (Shurgard Self Storage) -- obtains permit for building in Rotterdam

      • LSG.NO (Lerøy Seafood Group) -- Q4 trading update: total harvest volume (GWT) of salmon and trout ex-Scottish Seafarm 56.8K vs year-ago 47.5

      • XXL.NO (XXL ASA) -- announces fully underwritten rights issue of NOK 600M; reports Q4 trading update

      • BIOPOR.DC (BioPorto) -- expects 2024 adjusted EBITDA (DKK 68M) - (DKK 73M) vs FactSet (DKK 73.4M)

    • M&A

      • HELN.SW (Helvetia Holding) -- Helvetia exploring sale of loss-making German insurance operations - Bloomberg

      • TKWY.NA (Just Eat Takeaway.com) -- completes sale of Grubhub to Wonder Group, Inc

      • BAER.SW (Julius Baer Group) -- BTG Pactual to acquire Julius Baer's Brazilian business for ~1B reais ($163.6M) -- Reuters, citing O Globo

      • BAER.SW (Julius Baer Group) -- Julius Baer Group confirms it is to sell its domestic Brazilian business to BTG Pactual

      • FING.B.SS (Fingerprint Cards) -- licenses iris recognition technology to Smart Eye for up to SEK 50M

      • DKSH.SW (DKSH Holding) -- acquires CLMO; terms undisclosed

      • FAGR.BB (Fagron) -- announces acquisition of CareFirst Specialty Pharmacy in North America and Injeplast in Brazil with combined enterprise value of ~ €30M

    • Healthcare

      • BGBIO.NO (BerGenBio) -- Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

      • VSC.GR (4SC) -- updates on Resminostat's (Kinselby) Marketing Authorisation Application; subject to EMA's decision, marketing authorisation approval is expected around mid-2025

  • Key rating changes

    • Upgrades

      • BKG.LN (Berkeley Group Holdings) -- to overweight from equal weight at Barclays

      • AED.BB (Aedifica) -- to buy from hold at Bernstein

      • LEG.GR (LEG Immobilien) -- to buy from hold at Jefferies

      • SIGN.SW (SIG Combibloc Group) -- to neutral from underperform at BNP Paribas Exane

      • ADS.GR (Adidas) -- to outperform from market perform at Bernstein

      • BOL.SS (Boliden) -- to neutral from sell at UBS

      • FNOX.SS (Fortnox) -- to hold from reduce at Kepler Cheuvreux

      • NOVO.B.DC (Novo Nordisk) -- to market perform from underperform at Bernstein

    • Downgrades

      • ALO.FP (Alstom) -- to sell from neutral at Goldman Sachs

      • SIKA.SW (Sika Group) -- to underweight from overweight at Barclays

      • PNN.LN (Pennon Group) -- to sell from hold at Deutsche Numis

      • FNOX.SS (Fortnox) -- to hold from buy at Jefferies

      • AKSO.NO (Aker Solutions) -- to neutral from buy at Sparebank 1 Markets

      • A5G.ID (AIB Group) -- to hold from buy at Deutsche Numis

      • TW.LN (Taylor Wimpey) -- to equal weight from overweight at Barclays

      • MNDI.LN (Mondi) -- to neutral from outperform at BNP Paribas Exane

      • VIV.FP (Vivendi) -- downgraded to neutral from outperform at Oddo

  • Data

    • Nikkei +1.97% to 40083.30

    • Hang Seng (1.70%) to 19354.42

    • Shanghai Composite +0.57% to 3225.08

    • S&P futures (8.3) vs prior close of 6020.5

    • €-$ +0.0006 or +0.06% to 1.0398

    • $-¥ +0.18 or +0.11% to 157.83

    • €-¥ +0.31 or +0.19% to 164.10

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE